144 related articles for article (PubMed ID: 29752937)
1. LncRNA THOR promotes human renal cell carcinoma cell growth.
Ye XT; Huang H; Huang WP; Hu WL
Biochem Biophys Res Commun; 2018 Jun; 501(3):661-667. PubMed ID: 29752937
[TBL] [Abstract][Full Text] [Related]
2. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA THOR promotes human osteosarcoma cell growth in vitro and in vivo.
Chen W; Chen M; Xu Y; Chen X; Zhou P; Zhao X; Pang F; Liang W
Biochem Biophys Res Commun; 2018 May; 499(4):913-919. PubMed ID: 29626476
[TBL] [Abstract][Full Text] [Related]
4. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
Shang Y
Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
[TBL] [Abstract][Full Text] [Related]
5. LncRNA THOR promotes tongue squamous cell carcinomas by stabilizing IGF2BP1 downstream targets.
Yang H; Fu G; Liu F; Hu C; Lin J; Tan Z; Fu Y; Ji F; Cao M
Biochimie; 2019 Oct; 165():9-18. PubMed ID: 31220513
[TBL] [Abstract][Full Text] [Related]
6. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling.
Xue J; Zhong S; Sun BM; Sun QF; Hu LY; Pan SJ
Cell Death Dis; 2019 Nov; 10(11):866. PubMed ID: 31727877
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth.
Jiao PF; Tang PJ; Chu D; Li YM; Xu WH; Ren GF
Front Oncol; 2021; 11():756148. PubMed ID: 34868966
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR.
Chen S; Ye H; Gong F; Mao S; Li C; Xu B; Ren Y; Yu R
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649829
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP1 over-expression in skin squamous cell carcinoma cells is essential for cell growth.
Liu Z; Wu G; Lin C; Guo H; Xu J; Zhao T
Biochem Biophys Res Commun; 2018 Jun; 501(3):731-738. PubMed ID: 29753746
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
[TBL] [Abstract][Full Text] [Related]
13. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z
Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248
[TBL] [Abstract][Full Text] [Related]
19. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.
Shi J; Zhang D; Zhong Z; Zhang W
Mol Med Rep; 2019 Oct; 20(4):3782-3792. PubMed ID: 31485634
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.
Katayama H; Tamai K; Shibuya R; Nakamura M; Mochizuki M; Yamaguchi K; Kawamura S; Tochigi T; Sato I; Okanishi T; Sakurai K; Fujibuchi W; Arai Y; Satoh K
Sci Rep; 2017 Sep; 7(1):12016. PubMed ID: 28931862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
